Methyl 2-(2-chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylate | 922507-80-0

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: Methyl 2-(2-chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylate
• 英文别名: methyl 2-(2-chloroacetyl)-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole-1-carboxylate
• CAS: 922507-80-0
• 化学式: C₁₆H₁₇ClN₂O₃
• 分子量: 320.77
• InChiKey: BCSIRYFYAKLJDK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  62.4
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Treatments of oxidative stress conditions
  申请人：The University of Vermont and State Agricultural College

  公开号：US10688150B2

  公开（公告）日：2020-06-23

  The present invention generally relates to systems and methods for treating certain oxidative stress conditions. In one aspect, compositions and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, a subject having pulmonary fibrosis. In some embodiments, an inhibitor of ERp57 (for example, thiomuscimol) and/or an inhibitor of GSTP (for example, TLK-199) may be used to treat the subject. Also provided in certain aspects of the present invention are kits for such therapies, methods for promoting such therapies, and the like.

  本发明一般涉及治疗某些氧化应激状况的系统和方法。在一个方面，本发明的组合物和方法可用于治疗具有氧化应激状况的受试者，例如，具有肺纤维化的受试者。在某些实施方案中，ERp57 的抑制剂（例如硫代麝香草酚）和/或 GSTP 的抑制剂（例如 TLK-199）可用于治疗受试者。本发明的某些方面还提供了用于此类疗法的试剂盒、促进此类疗法的方法等。
• Methods and compositions for restoring homeostatic capacity of a subject
  申请人：Palo Alto Investors

  公开号：US10835134B2

  公开（公告）日：2020-11-17

  Methods of restoring homeostatic capacity of a subject are provided. Aspects of the invention further include compositions, systems and devices for practicing the methods. The methods and compositions described herein find use in a variety of applications. Aspects of certain embodiments of the methods include modulating a subject's autonomic nervous system in a manner sufficient to restore the homeostatic capacity of the subject. Aspects of other embodiments of the invention include administering to the subject an amount of an apoptosis modulator effective to at least partially restore homeostatic function of the neuroendocrine system of the subject.

  本发明提供了恢复受试者体内平衡能力的方法。本发明的各个方面还包括用于实施这些方法的组合物、系统和设备。本文所述的方法和组合物可用于多种应用。本发明方法的某些实施方案包括以足以恢复受试者平衡能力的方式调节受试者的自律神经系统。本发明其他实施方案的方面包括向受试者施用一定量的细胞凋亡调节剂，其有效量至少可部分恢复受试者神经内分泌系统的平衡功能。
• Agents for treating neurodegenerative diseases
  申请人：Stockwell R. Brent

  公开号：US20070027164A1

  公开（公告）日：2007-02-01

  The present invention relates to compounds effective in preventing neuronal cell death, which may be used in the treatment of neurodegenerative diseases. It is based, at least in part, on the discovery that particular compounds were effective in preventing neuronal death in model systems of Huntington's Disease.
• TREATMENTS OF OXIDATIVE STRESS CONDITIONS
  申请人：The University of Vermont and State Agricultural College

  公开号：US20150157686A1

  公开（公告）日：2015-06-11

  The present invention generally relates to systems and methods for treating certain oxidative stress conditions. In one aspect, compositions and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, a subject having pulmonary fibrosis. In some embodiments, an inhibitor of ERp57 (for example, thiomuscimol) and/or an inhibitor of GSTP (for example, TLK-199) may be used to treat the subject. Also provided in certain aspects of the present invention are kits for such therapies, methods for promoting such therapies, and the like.
• Methods and Compositions for Restoring Homeostatic Capacity of a Subject
  申请人：Palo Alto Investors

  公开号：US20150359888A1

  公开（公告）日：2015-12-17

  Methods of restoring homeostatic capacity of a subject are provided. Aspects of the invention further include compositions, systems and devices for practicing the methods. The methods and compositions described herein find use in a variety of applications.